Hidden Medical Devices in the School Setting: What the School Nurse Needs to Know About the Safe Use of Baclofen Pumps

Abstract

One of the “hidden” medical devices in the school setting is the baclofen pump, which is used for the treatment of spasticity. The goals of spasticity treatment are to decrease muscle tone, deformity, and pain in order to maximize function and ease of care for both child and caregiver. The use of an intrathecal baclofen pump, often for children with cerebral palsy, spinal cord injury, brain injury, or stroke, has been effective in spasticity treatment. It is important for school nurses to be aware of the safety implications associated with this type of device. The Specialized Health Needs Interagency Collaboration (SHNIC) program at the Kennedy Krieger Institute has complied education and materials that explain the use of baclofen pumps in children with spasticity and the role of the school nurse in providing staff training, developing emergency care plans, and creating a safe school environment for children with special health needs.

Keywords

Baclofen intrathecal baclofen (ITB)medical devices cerebral palsy spinal cord injury traumatic brain injury children with special health needs SHNIC factsheet emergency plan

Get full access to this article

View all access options for this article.

References

Albright

A. L.

(1995). Baclofen in the treatment of cerebral palsy. Journal of Child Neurology, 11(2), 77-83.

Awaad

Rizk

(2012). Spasticity in children. Journal of Taibah University Medical Sciences, 7(2), 53-60.

Berman

C. M.

Eppinger

M. A.

Mazzola

C. A.

(2014). Understanding the reasons for delayed referral for intrathecal baclofen therapy in pediatric patients with severe spasticity. Child’s Nervous System, 31(3), 405-403. doi:10.1007/s00381-014-2591-4

Fjelstad

Hommelstad

Sorteberg

(2009). Infections related to intrathecal baclofen therapy in children and adults: Frequency and risk factors. Journal of Neurosurgery: Pediatrics, 4(5), 487-493.

Kraus

Gegenleitner

Svehlik

Novak

Steinwender

Singer

(2017). Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy. European Journal of Paediatric Neurology, 21(3), 565-569.

Medtronic. (2017a). Baclofen pump for ITB therapy with Lioresal Intrathecal (baclofen infection). Retrieved from http://www.baclofenpump.com/living/index.htm

Medtronic. (2017b). Pump partner app. Retrieved from http://www.baclofenpump.com/living/patient-support/pump-app/index.htm

Murphy

N. A.

Irwin

M. C. N.

Hoff

(2002). Intrathecal baclofen therapy in children with cerebral palsy: Efficacy and complications. Archive of Physical Medicine and Rehabilitation, 83(12), 1721-1725.

Pandyan

A. D.

Gregoric

Barnes

M. P.

Wood

Van Wikcj

Burridge

. . . Johnson

G. R.

(2005). Spasticity: Clinical perceptions, neurological realities and meaningful measurement. Disability and Rehabilitation, 27(1-2), 2–6. doi:10.1080/09638280400014576

10.

Ridley

Rawlins

P. K.

(2006). Intrathecal baclofen therapy: Ten steps towards best practice. Journal of Neuroscience Nursing, 38(2), 72-82.

11.

Tilton

(2009). Management of spasticity in children with cerebral palsy. Seminars in Pediatric Neurology, 16(2), 82-89.

12.

Vender

J. R.

Hester

Waller

J. L.

Rekito

Lee

M. R.

(2006). Identification and management of intrathecal baclofen pump complications: A comparison of pediatric and adult patients. Journal of Neurosurgery, 104, 9-15.

13.

Ward

Hayden

Dexter

Scheinberg

(2009). Continuous intrathecal baclofen for children with spasticity and/or dystonia: Goal attainment and complications associated with treatment. Journal of Paediatrics and Child Health, 45(12), 720-726. doi:10.1111/j.1440-1754.2009.01601.x

14.

Woolf

S. M.

Baum

C. R.

(2017). Baclofen pumps—Uses and complications. Pediatric Emergency Care, 33(4), 271-277.